Table 2.
Serious adverse events | RR (95 % CI) | Trials (n) | Patients (n) |
---|---|---|---|
Liver failure | 0.35 (0.11–1.15) | 4 | 241 |
Spontaneous bacterial peritonitis | 0.86 (0.32–2.30) | 2 | 278 |
Variceal haemorrhage | 0.46 (0.28–0.98) | 9 | 681 |
Hepatorenal syndrome | 0.47 (0.21–1.04) | 3 | 278 |
Overall | 0.47 (0.36–0.60) | 24 | 1487 |
(adapted from Gluud et al. 2016)